XML 23 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Investments, cost $ 1,803,609 $ 1,792,304 [1]
Deferred financing costs, net $ 6,178 $ 7,628
Common stock par or stated value per share (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common stock, shares issued (in shares) 55,299,484 56,958,440
Common stock, shares outstanding (in shares) [2] 55,299,484 56,958,440
Non-controlled, non-affiliated investments    
Investments, cost $ 1,580,844 $ 1,617,126
Non-controlled, affiliated investments    
Investments, cost 140,344 91,476
Controlled investments    
Investments, cost $ 82,421 $ 83,702
[1] Represents amortized cost for debt securities and cost for equity investments.
[2] As discussed in Note 3, the Company completed a two-to-one reverse stock split, effective as of September 21, 2021. The shares outstanding used in the computation of net asset value per share reflect the reverse stock split on a retroactive basis.